Study finds no short-term heart risks from ADHD drugs in adults

02/26/2013 | DailyRx.com

Researchers looked at the records of nearly 300,000 adult patients with attention-deficit/hyperactivity disorder and found that those who took amphetamines or atomoxetine were not more likely to develop stroke, heart attack or other serious heart problems during the first few months of treatment than those who didn't take the drugs. The study appeared in the journal PLoS One.

View Full Article in:

DailyRx.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Counsel I – Clinical Contracts
Gilead Sciences
Foster City, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Vice President, Idaho Regional Director
PacificSource
Boise, ID